Skip to content
Trial Agents

LMU Klinikum Muenchen AöR

LMU Klinikum Muenchen AöR is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
2recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A randomized, 2-arm non-comparative phase II study on the efficacy of atezolizumab and Roche bevacizumab (Atezo/Bev) followed by on-demand selective TACE (sdTACE) upon detection of disease progression or of initial synchronous treatment with TACE and Atezo/Bev on objective response rate in the treatment of unresectable hepatocellular carcinoma patients (DEMAND)

Sponsor Klinikum der Universitaet Muenchen AöR

Start (EU)
Latest update
Estimated end
Not reported

A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose Range-finding, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALXN2420, a Growth Hormone Receptor Antagonist, Administered Subcutaneously in Combination with Somatostatin Analogs in Adult Participants with Acromegaly

Sponsor Alexion Pharmaceuticals Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for LMU Klinikum Muenchen AöR?

The 2026-10-09 snapshot links LMU Klinikum Muenchen AöR to 5 distinct CTIS trials. Recorded services include Laboratory services, Safety reporting & pharmacovigilance. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for LMU Klinikum Muenchen AöR?

The most frequently recorded therapeutic areas are Hepatology, Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to LMU Klinikum Muenchen AöR conducted?

The linked trials record locations in 12 countries, including Italy, Germany, Hungary, Poland, Belgium. These are trial locations, not confirmed office locations or countries where LMU Klinikum Muenchen AöR delivered services.

What can this page tell me about LMU Klinikum Muenchen AöR's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under LMU Klinikum Muenchen AöR. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • LMU Klinikum Muenchen AöR

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.